Personalized Diagnostics and Therapy for Cardiovascular Diseases

Dear Colleagues,

The aim of this Special Issue is to provide a comprehensive platform for the dissemination of cutting-edge research, innovative strategies, and evidence-based practices in the field of cardiovascular prevention and therapy. Cardiovascular diseases (CVDs) remain a global health challenge, and this Special Issue seeks to bring together researchers, clinicians, and experts to address the multifaceted aspects of CVD prevention, with the ultimate goal of reducing the burden of CVDs worldwide.

The scope of this Special Issue encompasses a wide range of topics related to cardiovascular prevention, including (but not limited to):

1. Risk assessment and prediction: exploration of novel methods for assessing cardiovascular risk, including genetic, biomarker, and imaging-based approaches, to enable more accurate identification of individuals at risk.
2. Lifestyle interventions: research on lifestyle modifications, such as diet, physical activity, and stress management, as primary and secondary prevention strategies for CVD.
3. Pharmacological interventions: evaluation of the latest pharmacological interventions, including lipid-lowering agents, antihypertensives, and antiplatelet therapies, in the context of CVD prevention.
4. Innovations in technology: examination of technological advancements, such as wearable devices, telehealth, and artificial intelligence, in enhancing the early detection and management of CVD risk factors.
5. Exercise physiology: research into the physiological mechanisms underlying the cardiovascular benefits of exercise and the development of personalized exercise prescriptions.
6. Global perspectives: insights into cardiovascular prevention efforts and challenges in different regions of the world.
7. Prevention programs and initiatives: case studies and evaluations of successful cardiovascular prevention programs, including community-based interventions and workplace wellness initiatives.

This Special Issue encourages contributions from diverse disciplines, including cardiology, sports medicine, epidemiology, genetics, and psychology. By fostering interdisciplinary collaboration and sharing the latest research and practices, we aim to advance our collective understanding of cardiovascular prevention and contribute to the global effort to reduce the burden of cardiovascular diseases.

Dr. Katharina Lechner
Dr. Patrick Müller
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.